Published in J Pharm Biomed Anal on August 01, 1996
The effects of polydeoxyribonucleotide on the survival of random pattern skin flaps in rats. Arch Plast Surg (2013) 0.82
Food supplement 20070721-GX may increase CD34+ stem cells and telomerase activity. J Biomed Biotechnol (2012) 0.76
Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study. Support Care Cancer (2013) 0.76
Immunoglobulin isotype isolated from human placental extract does not interfere in complement-mediated bacterial opsonization within the wound milieu. FEBS Open Bio (2015) 0.75
Novel Anti-Melanogenesis Properties of Polydeoxyribonucleotide, a Popular Wound Healing Booster. Int J Mol Sci (2016) 0.75
Stimulative Effects of Hominis Placental Pharmacopuncture Solution Combined with Zinc-oxide Nanoparticles on RAW 264.7 Cells: ZnO HPPS more easily stimulates RAW 264.7 cells. J Pharmacopuncture (2012) 0.75
Effects of Porcine Placenta Extract Ingestion on Ultraviolet B-induced Skin Damage in Hairless Mice. Korean J Food Sci Anim Resour (2015) 0.75
Effect of Porcine Placenta Extract from Subcritical Water Extraction on Photodamage in Human Keratinocytes. Korean J Food Sci Anim Resour (2015) 0.75
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82
Clustered cases of pneumonia among healthcare workers over a 1-year period in three Italian hospitals: applying the WHO SARS alert. Infection (2006) 1.39
GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses. Br J Pharmacol (2011) 1.00
Erdheim-Chester disease: clinical and radiological findings. Radiol Med (2009) 0.94
Study of bioequivalence of magnesium and sodium valproates. J Pharm Biomed Anal (1991) 0.90
MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol (2002) 0.90
Symptomatic subtotal occlusion of the innominate artery treated with balloon angioplasty and stenting. J Endovasc Ther (2000) 0.87
Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cell Biochem Funct (1999) 0.84
Cytotoxicity of the venom of Pelagia noctiluca forskål (Cnidaria: Scyphozoa). Toxicon (2002) 0.83
Simultaneous HPLC determination of multiple components in a commercial cosmetic cream. J Pharm Biomed Anal (1998) 0.82
Characterization of new small ruminant lentivirus subtype B3 suggests animal trade within the Mediterranean Basin. J Gen Virol (2011) 0.81
Device-specific risk of needlestick injury in Italian health care workers. JAMA (1994) 0.81
Methyleugenol in Ocimum basilicum L. Cv. genovese gigante. J Agric Food Chem (2001) 0.81
N,N-dialkylaminosubstituted chromones and isoxazoles as potential anti-inflammatory agents. Farmaco (1999) 0.80
Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine (2008) 0.80
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. Curr Cancer Drug Targets (2010) 0.80
Integrated biomarker analysis in the earthworm Lumbricus terrestris: application to the monitoring of soil heavy metal pollution. Chemosphere (2012) 0.80
Histological and immunohistochemical study of the bronchial stump with flap coverage in an animal model. Eur Surg Res (2003) 0.80
Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation? Clin Sci (Lond) (1995) 0.79
Synthesis in solution of oligodeoxynucleotides and some their 5'- and 3'-linked derivatives. Farmaco (1993) 0.79
HIV-1 reverse transcriptase is capable of elongating derivatives of sequence specific noncomplementary oligodeoxynucleotides. Biochem Mol Biol Int (1998) 0.78
Pharmacokinetics of zidovudine in HIV-positive patients with liver disease. J Clin Pharmacol (1994) 0.78
Antigenic variability of ovine lentivirus isolated in Italy. Vet Res Commun (2004) 0.78
Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc. FASEB J (2005) 0.78
Effects of insulin and dexamethasone on adenine nucleotide levels in cultured hepatocytes from adult rat. Cell Biochem Funct (1988) 0.78
Cytotoxic, DNA-damaging and mutagenic properties of 2,6-dimethoxy-1,4-benzoquinone, formed by dimethophrine-nitrite interaction. J Pharmacol Exp Ther (1988) 0.78
Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells. Exp Cell Res (1993) 0.77
Quantitative EEG effects and drug plasma concentration of phenobarbital, 50 and 100 mg single-dose oral administration to healthy volunteers: evidence of early CNS bioavailability. Neuropsychobiology (1991) 0.77
Interaction of oligonucleotides conjugated to substituted chromones and coumarins with HIV-1 reverse transcriptase. Antisense Nucleic Acid Drug Dev (1999) 0.77
A novel dimeric fluoropyrimidine molecule behaves as a remote precursor of 5-fluoro-2'-deoxyuridine in human erythrocytes. Biochem Pharmacol (1994) 0.77
Oligonucleotide degradation contributes to resistance to antisense compounds. Anticancer Drugs (1993) 0.77
SAMe versus placebo: a double blind comparison in major depressive disorders. Adv Biochem Psychopharmacol (1982) 0.76
Inhibition of DNA polymerase alpha expression and cell growth, a possible triple helix mechanism. Antisense Nucleic Acid Drug Dev (1996) 0.76
Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine (2008) 0.76
Seroconversion against SU5 derived synthetic peptides in sheep experimentally infected with different SRLV genotypes. Vet Microbiol (2009) 0.75
Genetic and antigenic characterization of the matrix protein of two genetically distinct ovine lentiviruses. Vet Microbiol (2005) 0.75
Formation of 2,6-dimethoxy-1,4-benzoquinone, a highly genotoxic compound, from the reaction of sodium nitrite with the sympathomimetic drug dimethophrine in acidic aqueous solution. Farmaco Sci (1988) 0.75
[3-Dialkylamino-substituted 2H-1,4-benzoxazines]. Farmaco Sci (1986) 0.75
In vitro and in vivo evaluation of the genotoxicity of N-nitrosooxprenolol. Pharmacol Toxicol (1992) 0.75
[Community control of arterial pressure in industry: the Necchi project for the control of hypertension in the workplace]. Med Lav (1988) 0.75
Estimate of the cosmological bispectrum from the MAXIMA-1 cosmic microwave background map. Phys Rev Lett (2002) 0.75
Toxicological studies of photosensitizer agents and photodegradable polyolefins. Eur J Toxicol Environ Hyg (1976) 0.75
[Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides]. Farmaco (1989) 0.75
Liquid phase synthesis and evaluation of antisense oligodeoxynucleotides to DNA polymerase alpha. Nucleic Acids Symp Ser (1991) 0.75
[Report on an experimental study with a new psychopharmacological agent: AF 1161 (trazodone)]. Riv Neurobiol (1973) 0.75
Community control of hypertension at the worksite in a metallurgical factory: results of 1-year follow-up. Eur J Epidemiol (1989) 0.75
Synthesis and HPLC assessment of N-nitrosoderivatives from six beta-adrenergic antagonists. Farmaco (1991) 0.75
Psychiatric emergencies and services availability: a comparison of two hospitals in Rome. Clin Ter (2004) 0.75
[Chemical and pharmacological research on derivatives of 1H-naphtho/2,1-b/pyran. V. Behavior of some 1-oxo-3-dialkylamino-1H-naphtho/2,1-b/pyrans substituted in the Mannich reaction]. Farmaco Sci (1975) 0.75
[Derivatives of pyrimidine 1,2-condensate. IV. Synthesis and pharmacological properties of the N,N-disubstituted 4-amino-2H-pyrido(1,2-a)pyrimidin- 2-ones and 2-amino-4H-pyrido(1,2-a)pyrmidin-4-ones]. Farmaco Sci (1988) 0.75
Anti-PKC activity of some 3-(dialkylamino)-1H-naphtho [2,1-B] pyran-1-ones. Farmaco (1998) 0.75
[Chemical and pharmacological research on derivatives of 1H-naphto/2,1-b/pyran. IV. Substituted 1-oxo-3-dialkylamino-1H-naphto/2,1-b/pyrans]. Farmaco Sci (1975) 0.75
HPLC analysis of the nitrosation products of chlordiazepoxide. Farmaco (1989) 0.75
Inhibition of neutrophil O(2)(-) production by unsymmetrical methylene derivatives of benzopyrans: their use as potential antiinflammatory agents. Eur J Med Chem (2001) 0.75
[Chemical and pharmacological research on derivatives of 1H-naphtho-(2,1-b)pyran. II. Synthesis of 1-oxo-2-dialkylaminomethyl-3-dialkylamino-1H-naphtho(2,1-b)pyran]. Farmaco Sci (1974) 0.75
Antiplatelet effect of 2-(diethylamino)-7-hydroxychromone. Pharmacol Res (1991) 0.75
Synthesis and hybridization properties of the conjugates of oligonucleotides and stabilization agents--II. Bioorg Med Chem (1997) 0.75
[Assay of 1,3-diiodo-2-propanol (Iothion) in various pharmaceutical preparations]. Farmaco Prat (1985) 0.75
[Double-contrast gastrography and gastroscopy in the diagnosis of gastric polyps. Personal experience]. Radiol Med (1986) 0.75
"Side" effects of HAART: decreasing and changing occupational exposure to HIV-infected patients. J Biol Regul Homeost Agents (2001) 0.75
HPLC determination of azidothymidine (AZT) and its metabolite in human plasma. Farmaco (1990) 0.75
[Chemical and pharmaceutical research on pyran derivatives. XI. Synthesis of 2-dialkylamino-4-oxo-10-methyl-4H-naphtho[2,3b]pyrans]. Farmaco Sci (1978) 0.75
[Chemistry and pharmacology of pyran derivatives. 16. Derivatives of 2-(dialkylamino)-7-methoxychromone with antiallergic activity]. Farmaco Sci (1985) 0.75
[Chemical and pharmacological research on pyran derivatives. XIII. Derivatives of 2H-pyrano/3,2-c/quinoline]. Farmaco Sci (1979) 0.75
[Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran]. Farmaco Sci (1986) 0.75
[Chemical and pharmacological research on derivatives of 1H-naphtho(2,1-b)pyran. I. Synthesis of 1-oxo-3-dialkylamino-1H-naphtho(2,1-b)pyran]. Farmaco Sci (1974) 0.75
[Derivatives of 1,2-condensed pyrimidines. II. Synthesis and pharmacological study of N,N-disubstituted 5-amino-7H-thiazol [3,2-a]pyrimdine-7-ones]. Farmaco Sci (1986) 0.75
Cosmology from MAXIMA-1, BOOMERANG, and COBE DMR cosmic microwave background observations. Phys Rev Lett (2001) 0.75
[Chemical and pharmacological research on pyran derivatives. VIII. Synthesis of 2-dialkylamino-7-methoxychromones and derivatives]. Farmaco Sci (1977) 0.75
Low clastogenic activity in vivo of the N-nitroso derivatives of 5 beta-adrenergic-blocking drugs proved to be potent genotoxins in vitro. Toxicol Lett (1994) 0.75
Characterization of hepatitis C virus genotypes in an hemodialysis unit in Paysandú, Uruguay. Rev Argent Microbiol (1999) 0.75
Alkaline extraction and reverse-phase high-performance liquid chromatography of adenine and pyridine nucleotides in human platelets. Anal Biochem (1987) 0.75
The paper electrophoretic study of ion pair formation. 3. Ion pair formation with quaternary ammonium ions. J Chromatogr (1968) 0.75
[Chemistry and pharmacology of pyrane derivatives. XVII. Synthesis of substituted 2-(dialkylamino)-3-formylchromones and their tricyclic derivatives]. Farmaco (1989) 0.75
[Chemical and pharmacological research on pyran derivatives. VII. Derivatives of naphto/1',2':5,6/pyran/2,3-c/pyrazole and of 12H-naphto/1',2':5,6/pyran/2,3-d/pyrimidine]. Farmaco Sci (1977) 0.75
[Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension]. Clin Ter (1993) 0.75
[Interaction of human immunodeficiency virus reverse transcriptase with oligonucleotide derivatives containing polycyclic aromatic groups at the 5'-terminus]. Mol Biol (Mosk) (1997) 0.75
Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives. Farmaco (1996) 0.75
Synthesis of ionones and carvone analogues: olfactory properties and preliminary toxicity assays. Eur J Med Chem (2000) 0.75
HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state. Farmaco (1992) 0.75
Tests for Gaussianity of the MAXIMA-1 cosmic microwave background map. Phys Rev Lett (2001) 0.75
[Chemical and pharmacological research on pyran derivatives. XII. Bis-(beta-chloroethyl)amino-substituted chromones and benzochromones]. Farmaco Sci (1979) 0.75
[Clinical and electroencephalographic correlations in a group of children with cerebral paralysis]. Riv Neurobiol (1969) 0.75
Nitrosation of propranolol under simulated gastric conditions. Carcinogenesis (1995) 0.75